Compile Data Set for Download or QSAR
Report error Found 25 Enz. Inhib. hit(s) with all data for entry = 805
TargetSubstance-P receptor(Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM292016(US10100030, Example 11)
Affinity DataIC50: 1.32nMpH: 7.4 T: 2°CAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 uL/well. DMSO solutions of a ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSubstance-P receptor(Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM292006(US10100030, Example 1)
Affinity DataIC50: 2.11nMpH: 7.4 T: 2°CAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 uL/well. DMSO solutions of a ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSubstance-P receptor(Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM292013(US10100030, Example 8)
Affinity DataIC50: 2.25nMpH: 7.4 T: 2°CAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 uL/well. DMSO solutions of a ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSubstance-P receptor(Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM292007(US10100030, Example 2)
Affinity DataIC50: 2.53nMpH: 7.4 T: 2°CAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 uL/well. DMSO solutions of a ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSubstance-P receptor(Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM292011(US10100030, Example 6)
Affinity DataIC50: 2.60nMpH: 7.4 T: 2°CAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 uL/well. DMSO solutions of a ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSubstance-P receptor(Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM292014(US10100030, Example 9)
Affinity DataIC50: 2.83nMpH: 7.4 T: 2°CAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 uL/well. DMSO solutions of a ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSubstance-P receptor(Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM292010(US10100030, Example 5)
Affinity DataIC50: 3.29nMpH: 7.4 T: 2°CAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 uL/well. DMSO solutions of a ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSubstance-P receptor(Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM292015(US10100030, Example 10)
Affinity DataIC50: 3.32nMpH: 7.4 T: 2°CAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 uL/well. DMSO solutions of a ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSubstance-P receptor(Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM292009(US10100030, Example 4)
Affinity DataIC50: 3.54nMpH: 7.4 T: 2°CAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 uL/well. DMSO solutions of a ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSubstance-P receptor(Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM292008(US10100030, Example 3)
Affinity DataIC50: 4.61nMpH: 7.4 T: 2°CAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 uL/well. DMSO solutions of a ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSubstance-P receptor(Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM292012(US10100030, Example 7)
Affinity DataIC50: 4.65nMpH: 7.4 T: 2°CAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 uL/well. DMSO solutions of a ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetSubstance-P receptor(Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM292017(US10100030, Example 12)
Affinity DataIC50: 7.44nMpH: 7.4 T: 2°CAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 uL/well. DMSO solutions of a ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCytochrome P450 3A4(Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM50220136(CHEMBL1471 | 5-(((2R,3S)-2-((R)-1-(3,5-bis(trifluo...)
Affinity DataIC50: 20nMpH: 7.4 T: 2°CAssay Description:A dimethyl sulfoxide (DMSO) solution of a test compound with a concentration 1000 times higher than the evaluation concentration was prepared, and a ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCytochrome P450 3A4(Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM292013(US10100030, Example 8)
Affinity DataIC50: 1.40E+3nMpH: 7.4 T: 2°CAssay Description:A dimethyl sulfoxide (DMSO) solution of a test compound with a concentration 1000 times higher than the evaluation concentration was prepared, and a ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCytochrome P450 3A4(Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM292011(US10100030, Example 6)
Affinity DataIC50: 2.60E+3nMpH: 7.4 T: 2°CAssay Description:A dimethyl sulfoxide (DMSO) solution of a test compound with a concentration 1000 times higher than the evaluation concentration was prepared, and a ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCytochrome P450 3A4(Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM292008(US10100030, Example 3)
Affinity DataIC50: 3.70E+3nMpH: 7.4 T: 2°CAssay Description:A dimethyl sulfoxide (DMSO) solution of a test compound with a concentration 1000 times higher than the evaluation concentration was prepared, and a ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCytochrome P450 3A4(Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM292015(US10100030, Example 10)
Affinity DataIC50: 3.80E+3nMpH: 7.4 T: 2°CAssay Description:A dimethyl sulfoxide (DMSO) solution of a test compound with a concentration 1000 times higher than the evaluation concentration was prepared, and a ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCytochrome P450 3A4(Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM292012(US10100030, Example 7)
Affinity DataIC50: 4.10E+3nMpH: 7.4 T: 2°CAssay Description:A dimethyl sulfoxide (DMSO) solution of a test compound with a concentration 1000 times higher than the evaluation concentration was prepared, and a ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCytochrome P450 3A4(Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM292017(US10100030, Example 12)
Affinity DataIC50: 4.60E+3nMpH: 7.4 T: 2°CAssay Description:A dimethyl sulfoxide (DMSO) solution of a test compound with a concentration 1000 times higher than the evaluation concentration was prepared, and a ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCytochrome P450 3A4(Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM292009(US10100030, Example 4)
Affinity DataIC50: 4.80E+3nMpH: 7.4 T: 2°CAssay Description:A dimethyl sulfoxide (DMSO) solution of a test compound with a concentration 1000 times higher than the evaluation concentration was prepared, and a ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCytochrome P450 3A4(Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM292016(US10100030, Example 11)
Affinity DataIC50: 4.90E+3nMpH: 7.4 T: 2°CAssay Description:A dimethyl sulfoxide (DMSO) solution of a test compound with a concentration 1000 times higher than the evaluation concentration was prepared, and a ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCytochrome P450 3A4(Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM292010(US10100030, Example 5)
Affinity DataIC50: 5.50E+3nMpH: 7.4 T: 2°CAssay Description:A dimethyl sulfoxide (DMSO) solution of a test compound with a concentration 1000 times higher than the evaluation concentration was prepared, and a ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCytochrome P450 3A4(Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM292006(US10100030, Example 1)
Affinity DataIC50: 6.20E+3nMpH: 7.4 T: 2°CAssay Description:A dimethyl sulfoxide (DMSO) solution of a test compound with a concentration 1000 times higher than the evaluation concentration was prepared, and a ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCytochrome P450 3A4(Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM292014(US10100030, Example 9)
Affinity DataIC50: 6.30E+3nMpH: 7.4 T: 2°CAssay Description:A dimethyl sulfoxide (DMSO) solution of a test compound with a concentration 1000 times higher than the evaluation concentration was prepared, and a ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetCytochrome P450 3A4(Human)
Kissei Pharmaceutical

US Patent
LigandPNGBDBM292007(US10100030, Example 2)
Affinity DataIC50: 1.30E+4nMpH: 7.4 T: 2°CAssay Description:A dimethyl sulfoxide (DMSO) solution of a test compound with a concentration 1000 times higher than the evaluation concentration was prepared, and a ...More data for this Ligand-Target Pair
In DepthDetails
US Patent